Apellis Pharmaceuticals Headquarters
Looking for information about Apellis Pharmaceuticals Headquarters? The links below have collected all the necessary data.
Jul 26, 2021 · Apellis Pharmaceuticals to Host Conference Call on August 9, 2021 to Discuss Second Quarter 2021 Financial Results. July 26, 2021. Apellis Announces Closing of Previously Announced Exchanges of Approximately $201.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock.
https://apellis.com/contact-us/
Contact Us Apellis. Call Us. (617) 977-5700 Main Office. (833) 866-3346 (833-TO-MEDINFO) Medical Information Call Center. Addresses. Main Office. 100 5th Avenue. Waltham, MA …
https://craft.co/apellis-pharmaceuticals/locations
Apellis Pharmaceuticals headquarters and office locations Apellis Pharmaceuticals is headquartered in Crestwood, KY and has 4 office locations across 2 countries. View Company
https://craft.co/apellis-pharmaceuticals
Jul 29, 2021 · Apellis Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level …Employees: 235
https://www.linkedin.com/company/apellis
Apellis Pharmaceuticals 22,563 followers on LinkedIn. Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies. At Apellis, we are ...Founded: 2008
https://apellis.com/about-us/our-team/
Meet the leadership team that guides development of targeted C3 therapies to inhibit diseases driven by excessive activation of the complement cascade. The team possesses decades of experience across pharmaceutical R&D, drug development, regulatory affairs, and business development.
https://investors.apellis.com/
August 9, 2021 - Apellis Pharmaceuticals Reports Second Quarter 2021 Financial Results July 29, 2021 - Apellis Pharmaceuticals to Host Conference Call on August 9, 2021 to Discuss Second Quarter 2021 Financial Results July 26, 2021 - Apellis Announces Closing of Previously Announced Exchanges of Approximately $201.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 ...
Have you found Apellis Pharmaceuticals Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|